You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence
Yawkey Center for Cancer Care 

U.S. News and World Report ranks Dana-Farber/Brigham and Women’s Cancer Center the top cancer hospital in New England; fourth in U.S.

July 15, 2014

U.S. News and World Report ranks Dana-Farber/Brigham and Women's Cancer Center the top hospital in New England for the 14th straight year.
 

Target growth-driving cells within tumors, not fastest-proliferating cells, new study suggests

July 30, 2014

Researchers find that targeting growth-driving cells within tumors, not the fastest-proliferating cells within tumors, may lead to more effective treatments.

Matthew Meyerson, MD, PhD in the lab 

Nineteen Dana-Farber scientists listed among world's most influential

July 01, 2014

In an affirmation of worldwide respect for the impact of Dana-Farber research, 19 basic scientists and clinical investigators at the Institute have been listed among "the world's most influential scientific minds." The ranking was based on how frequently their research discoveries have been cited by peers in the past decade.
 

New view of stomach cancer could hasten better therapies
July 23, 2014

In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers from Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular abnormalities.

Dana-Farber Cancer Institute recognized as a Magnet® organization for excellence in nursing and patient care
July 16, 2014

Dana-Farber Cancer Institute is recognized as a Magnet® organization for excellence in nursing and patient care for the third time.

Antibody halts cancer-related wasting condition
July 13, 2014

Dana-Farber scientists identify a protein that is a cause of cachexia, a severe wasting of fat and muscle in half of all cancer patients, and show that blocking the protein in mice can prevent or halt the debilitating condition.

Study supports newborn screening for ‘bubble boy disease’ (Boston Globe)

July 31, 2014

Dr. Sung-Yun Pai led a study that found children with the immune disorder known as “bubble boy disease” who received stem cell transplants within three-and-a-half months of birth had the highest rates of survival.

 

Scientists warned on cancer target (Yahoo.com)
July 31, 2014

Dr. Kornelia Polyak led a study that suggests that the most dangerous cancer cells are not necessarily those that proliferate the fastest

The Wrong Approach to Breast Cancer (The New York Times)
July 28, 2014

In a 2013 study conducted by Shoshana Rosenberg, ScD, women younger than 40 with no increased genetic risk and disease in one breast believed that within five years, 10 out of 100 of them would develop it in the other.

Four biological subtypes of stomach cancer defined (ASCO Post)
July 25, 2014

Dr. Adam Bass co-authored a study that developed a molecular classification that divides gastric cancer into four major genomic subtypes

Fresh Concerns About a Hysterectomy Procedure Linked to Cancer Spread (New York Times)
July 23, 2014

Dr. Suzanne George commented on a study showing that undetected tumors in women having hysterectomies are more common than many experts had thought, a conclusion that is fueling calls to limit or eliminate a particular hysterectomy procedure.

100 Hospitals and Health Systems With Great Oncology Programs (Becker's Hospital Review)
July 22, 2014

Becker's Hospital Review named Dana-Farber/Brigham and Women's Cancer Center to the 2014 edition of "100 Hospitals and Health Systems With Great Oncology Programs."

Study Discounts Testosterone Therapy for Early Prostate Cancer (The New York Times)
July 14, 2014

An editorial written by physicians at Dana-Farber supports a study showing there is no compelling evidence to justify using testosterone suppression therapy on men with early-stage prostate cancer.

Mindfulness Meditation(3)

July 31, 2014

11:30 AM - 1:00 PM

Smith 330, Stoneman Patient Services Suite

Presented by the Leonard P. Zakim Center for Integrative Therapies

Elana Rosenbaum, LICSW is a leader in the clinical application of mindfulness meditation to cancer care 

Join us for some mindfulness-based stress reduction and breath awareness. 

Adult patients, family members and caregivers are welcome. 

Registration required. For more information and to register, please contact the Zakim Center 

at 617-632-3322 or at Zakim_Center@dfci.harvard.edu

You may also visit us at Dana-Farber.com/Zakim.

more

Gynecologic and Breast Cancer Caregiver Support Group(2)

July 31, 2014

12:00 PM - 1:00 PM

Call for details

For caregivers of inpatients with a gynecologic or breast cancer diagnosis.  Lunch is provided.  For more information, please call Bobbi Allison at 617-732-5670. more

Twitter Chat: Living with Brain Tumors

July 31, 2014

1:00 PM - 2:00 PM

Online

Dana-Farber is partnering with the National Brain Tumor Society to host a Twitter chat about living with brain tumors. The chat will take place from 1-2pmEST on July 31 and will include special guest Dr. David Reardon, Dana-Farber's clinical director of the Center for Neuro-Oncology. To participate in the chat follow @DanaFarber and @NBTStweets on Twitter and use the hashtag #DFCIchat. more

  •  
  • Patient referral information, clinical resources and more.

  • Make an Appointment


    For adults:
    877-442-3324

    For children:
    888-733-4662


    Or complete the online form.

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Dana-Farber Blog

    Insight Blog screenshot 

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight 

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now